Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= GALNS ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: GALNS * **<color #00a2e8>Official Name</color>**: galactosamine (N-acetyl)-6-sulfatase * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2588|2588]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/P34059|P34059]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=GALNS&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GALNS|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/612222|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq, Jul 2008]. * **<color #00a2e8>UniProt Summary</color>**: N/A <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |Phosphodiest| |Sulfatase| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |N-acetylgalactosamine-6-sulfatase activity| |N-acetylgalactosamine-4-sulfatase activity| |sulfuric ester hydrolase activity| |keratan sulfate catabolic process| |arylsulfatase activity| |keratan sulfate metabolic process| |sulfur compound catabolic process| |glycosaminoglycan catabolic process| |aminoglycan catabolic process| |azurophil granule lumen| |lysosomal lumen| |mucopolysaccharide metabolic process| |glycosaminoglycan metabolic process| |aminoglycan metabolic process| |carbohydrate derivative catabolic process| |sulfur compound metabolic process| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |leukocyte mediated immunity| |exocytosis| |leukocyte activation| |oxoacid metabolic process| |secretion by cell| |organic acid metabolic process| |carbohydrate derivative metabolic process| |export from cell| |macromolecule catabolic process| |organonitrogen compound catabolic process| |cell activation| |immune effector process| |secretion| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |immune response| |extracellular region| |vesicle-mediated transport| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='default' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.94| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> No correlation found to any other genes in chemogenomics. </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 6377 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 4.43 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='GALNS Expression in NALM6 Cells: 4.43'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2026/01/07 22:36by 127.0.0.1